Arkolith/Insider Trading/DAWN/Form 4

AI Day1 LLC

10% OwnerDay One Biopharmaceuticals, Inc. (DAWN) · full profile →Form 4 · filed Apr 27, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2026Tender(U)12.9M$21.50$278.0M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 23, 2026Disposed to issuer(D)828K$21.50$17.8M0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-182440) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML